Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-8
Closed -$605 873
2026
Q1
$605 Buy
+8
New +$601 ﹤0.01% 762
2025
Q1
Sell
-500
Closed -$36K 626
2024
Q4
$36K Hold
500
0.01% 372
2024
Q3
$40.7K Hold
500
0.01% 352
2024
Q2
$37.1K Buy
+500
New +$37.5K 0.01% 354
2024
Q1
Sell
-80
Closed -$5.72K 667
2023
Q4
$5.72K Buy
+80
New +$5.57K ﹤0.01% 458

Other funds holding HOLX

Arlington Trust's HOLX Position: Q2 2026 in Review

Arlington Trust sold out of Hologic (HOLX) in Q2 2026, closing a stake of 8 shares — an estimated $605 sold.

Arlington Trust first reported a position in HOLX in Q4 2023 and held it in 5 quarters. The position peaked at $40.7K in Q3 2024. 1 fund tracked by Wall St. Rank holds HOLX as of Q2 2026.

  • Arlington Trust reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Arlington Trust sold 8 Hologic shares in Q2 2026, an estimated $605.
  • Arlington Trust first reported a position in Hologic in Q4 2023 and held it in 5 quarters.
  • Arlington Trust's Hologic position peaked at $40.7K in Q3 2024.
  • 1 fund tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Arlington Trust's 13F filing for Q2 2026, filed 7 Jul 2026.